globalbarry. Company Intelligence Engine

Anbio Biotechnology

NNNN CIK 0001982708 · In Vitro & In Vivo Diagnostic Substances (SIC 2835)

Disclosed SEC business address
FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, 2M, 60308

Anbio Biotechnology (ticker NNNN, CIK 0001982708) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: In Vitro & In Vivo Diagnostic Substances (SIC 2835). Disclosed business address country: Germany. Every item is grounded on the cited public source — no figures are fabricated.

21 exposure relationships mapped 14 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835)
  • FACT Country of disclosed business address: Germany
  • FACT F-3ASR filed 2026-07-09 source ↗

You've reached this month's free company deep views

The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.

Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.